Health
Study Identifies Cytokine Target for Treatment-Resistant Hemophilia A – MD Magazine
Elevated B cell activating factor levels in children and adults were associated with the development of FVIII inhibitors, which may lead to FVIII infusion failures….
Findings from a new study shed light on the mechanisms behind patient unresponsiveness to coagulation protein therapy for hemophilia A.
More specifically, investigators note a key target that may lead to treatment failure in up to 30% of patients.
Currently, hemophilia is the most common inherited bleeding disorder, which affects 1 in 10,000 men across the globe. Since patients lack coagulation factor VIII (FVIII), therapies are typically aimed at infusions to replace the missing protein.
Some patients,…
-
General19 hours agoByford rail extension opening marks final stage of Perth Metronet
-
General20 hours agoMango the muster cat draws attention to western Queensland’s ongoing recovery
-
Business23 hours agoWhat $10,000 invested in the iShares S&P 500 IVV ETF could be in 10 years
-
Noosa News21 hours agoTeenager airlifted to hospital after shark bites his stomach on Thursday Island in Far North Queensland